Compare PCRX & UTL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PCRX | UTL |
|---|---|---|
| Founded | 2006 | 1984 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Power Generation |
| Sector | Health Care | Utilities |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.0B | 906.0M |
| IPO Year | 2010 | 1995 |
| Metric | PCRX | UTL |
|---|---|---|
| Price | $23.78 | $53.85 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 4 | 2 |
| Target Price | $30.25 | ★ $56.50 |
| AVG Volume (30 Days) | ★ 518.7K | 106.2K |
| Earning Date | 05-07-2026 | 05-05-2026 |
| Dividend Yield | N/A | ★ 3.54% |
| EPS Growth | ★ 107.44 | 1.37 |
| EPS | 0.16 | ★ 2.97 |
| Revenue | ★ $541,533,000.00 | $536,000,000.00 |
| Revenue This Year | $6.78 | $7.93 |
| Revenue Next Year | $8.54 | $5.85 |
| P/E Ratio | $150.19 | ★ $18.06 |
| Revenue Growth | ★ 26.04 | 8.33 |
| 52 Week Low | $18.80 | $45.11 |
| 52 Week High | $27.99 | $59.99 |
| Indicator | PCRX | UTL |
|---|---|---|
| Relative Strength Index (RSI) | 57.59 | 55.80 |
| Support Level | $23.74 | $50.38 |
| Resistance Level | $23.94 | N/A |
| Average True Range (ATR) | 0.73 | 1.06 |
| MACD | 0.11 | 0.10 |
| Stochastic Oscillator | 75.36 | 68.30 |
Pacira BioSciences Inc is a provider of non-opioid pain management and regenerative health solutions dedicated to advancing and improving outcomes for healthcare practitioners and their patients. The company's commercialized non-opioid treatments: EXPAREL a long-acting, local analgesic currently approved for postsurgical pain management; ZILRETTA, an extended-release, intra-articular, corticosteroid injection indicated for the management of osteoarthritis; and iovera, a novel, handheld device for delivering immediate, long-acting, drug-free pain control using precise, controlled doses of cold temperature to a targeted nerve. In addition, it is developing PCRX-201 (enekinragene inzadenovec), a novel gene therapy vector platform for the treatment of osteoarthritis of the knee.
Unitil Corp is a holding company, through its subsidiaries it is engaged in the local distribution of electricity and natural gas throughout its service territories in the states of New Hampshire, Massachusetts, and Maine. The Company has two operating and reportable segments: Utility Electric Operations and Utility Gas Operations. Majority of revenue is gained from Electric Segment.